Treatment Registry
TR-0321 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by NiceRx · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$299

Medication · Homepage — first month promo / then ongoing$299

Added from the figures recorded below.

Price

TermPer monthCharged today
Homepage — first month promo / then ongoing

Compounded Tirzepatide First month: $199 $299 $299 every month thereafter, cancel anytime

source

Per month$299Charged today$199
Visit NiceRx

We earn nothing from this link. NiceRx has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

StatesAll states except Alaska, Kansas, Mississippi, and New Jersey
PrescriberAsynchronous review
Cancellation“There's no sign-up or cancellation fee, so you can stop your membership at any time.”

Not yet checked: pharmacy, membership and consult fee.

Recorded from nicerx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0321
Readings
1

Related records

What else NiceRx sells

All NiceRx programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). NiceRx compounded tirzepatide (TR-0321). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0321

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.